Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashleigh Shannon

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Antiviral Research|December 25, 2022
Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2Ashleigh Shannon, Bruno Canard
Antiviral Research|December 18, 2024
Nucleotide analogues and mpox: Repurposing the repurposableAshleigh Shannon, Bruno Canard
NAR Genomics and Bioinformatics|April 15, 2020
A N7-guanine RNA cap methyltransferase signature-sequence as a genetic marker of large genome, non-mammalian <i>Tobaniviridae</i>François Ferron, Humberto J Debat, Ashleigh Shannon, et al.
Journal of Virology|May 20, 2021
Structure and Sequence Requirements for RNA Capping at the Venezuelan Equine Encephalitis Virus RNA 5' EndOney Ortega Granda, Coralie Valle, Ashleigh Shannon, et al.
Reviews in Medical Virology|August 12, 2020
Drugs against SARS-CoV-2: What do we know about their mode of action?Coralie Valle, Baptiste Martin, Franck Touret, et al.
Journal of Virological Methods|November 9, 2020
A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complexCecilia Eydoux, Veronique Fattorini, Ashleigh Shannon, et al.
Nucleic Acids Research|October 20, 2022
A second type of N7-guanine RNA cap methyltransferase in an unusual locus of a large RNA virus genomeAshleigh Shannon, Bhawna Sama, Pierre Gauffre, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2021
Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with <i>In Vitro</i> and <i>In Vivo</i> Activity against Dengue and Other FlavivirusesSteven S Good, Ashleigh Shannon, Kai Lin, et al.
Antiviral Research|April 14, 2020
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sitesAshleigh Shannon, Nhung Thi-Tuyet Le, Barbara Selisko, et al.
Antiviral Research|November 7, 2024
The effects of Remdesivir's functional groups on its antiviral potency and resistance against the SARS-CoV-2 polymeraseBhawna Sama, Barbara Selisko, Camille Falcou, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Antiviral Research|December 25, 2022
Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2Ashleigh Shannon, Bruno Canard
Antiviral Research|December 18, 2024
Nucleotide analogues and mpox: Repurposing the repurposableAshleigh Shannon, Bruno Canard
NAR Genomics and Bioinformatics|April 15, 2020
A N7-guanine RNA cap methyltransferase signature-sequence as a genetic marker of large genome, non-mammalian <i>Tobaniviridae</i>François Ferron, Humberto J Debat, Ashleigh Shannon, et al.
Journal of Virology|May 20, 2021
Structure and Sequence Requirements for RNA Capping at the Venezuelan Equine Encephalitis Virus RNA 5' EndOney Ortega Granda, Coralie Valle, Ashleigh Shannon, et al.
Reviews in Medical Virology|August 12, 2020
Drugs against SARS-CoV-2: What do we know about their mode of action?Coralie Valle, Baptiste Martin, Franck Touret, et al.
Journal of Virological Methods|November 9, 2020
A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complexCecilia Eydoux, Veronique Fattorini, Ashleigh Shannon, et al.
Nucleic Acids Research|October 20, 2022
A second type of N7-guanine RNA cap methyltransferase in an unusual locus of a large RNA virus genomeAshleigh Shannon, Bhawna Sama, Pierre Gauffre, et al.
Antimicrobial Agents and Chemotherapy|August 23, 2021
Evaluation of AT-752, a Double Prodrug of a Guanosine Nucleotide Analog with <i>In Vitro</i> and <i>In Vivo</i> Activity against Dengue and Other FlavivirusesSteven S Good, Ashleigh Shannon, Kai Lin, et al.
Antiviral Research|April 14, 2020
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sitesAshleigh Shannon, Nhung Thi-Tuyet Le, Barbara Selisko, et al.
Antiviral Research|November 7, 2024
The effects of Remdesivir's functional groups on its antiviral potency and resistance against the SARS-CoV-2 polymeraseBhawna Sama, Barbara Selisko, Camille Falcou, et al.
Pageof 2